Executive Informatics Sales Specialist

Taiwan

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Genomic Technology, Biotechnology, HealthcareIndustries

Requirements

Candidates should have 10+ years of experience in Life Science or Clinical Diagnostics industries, typically with a Master's degree or a preferred PhD. Proficiency in machine learning frameworks like TensorFlow, Scikit-learn, or PyTorch, and programming languages such as Python or R is required. Deep expertise in bioinformatics and multi-omics domains including genomics, proteomics, or metabolomics is essential, along with strong communication and influencing skills. Willingness to conduct approximately 50% of customer visits onsite is also necessary.

Responsibilities

The Executive Informatics Sales Specialist will design and implement informatics solutions for Illumina's multiomics products to drive customer workflow efficiency and business growth. This involves analyzing large datasets, developing machine learning models, and providing subject matter expertise in multi-omics domains. The role includes attending pre-sales activities, leveraging technical tools, collaborating with sales, marketing, and service teams to achieve revenue goals, coaching the sales specialist team, and establishing Illumina informatics product branding through external presentations.

Skills

informatics solutions

multiomics products

clinical research

AI drug discovery

cloud computing

bioinformatics

machine learning

data analysis

sales

customer relationship management

product branding

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free